Tracking short-term biodistribution and long-term clearance of SPIO tracers in magnetic particle imaging

Area of Science:

• Medical Imaging
• Biomedical Engineering
• Nanotechnology

Background:

• Magnetic particle imaging (MPI) is an emerging tracer-based medical imaging modality.
• MPI utilizes non-radioactive, kidney-safe superparamagnetic iron oxide (SPIO) tracers.
• MPI provides quantitative, high-contrast, and high-SNR images for various applications.

Purpose of the Study:

• To assess the biodistribution and clearance of two common MPI tracers: Ferucarbotran and LS-oo8.
• To demonstrate the capability of 3D MPI in quantitatively evaluating tracer dynamics in vivo.

Main Methods:

• Utilized 3D Magnetic Particle Imaging (MPI) to image superparamagnetic iron oxide (SPIO) tracers.
• Quantitatively assessed short-term biodistribution of Ferucarbotran and LS-oo8 tracers.
• Tracked long-term clearance of these tracers from the body in vivo.

Main Results:

• Successfully demonstrated 3D MPI's ability to quantitatively assess short-term biodistribution.
• Showcased 3D MPI's effectiveness in tracking long-term clearance of SPIO tracers in vivo.
• Validated the utility of Ferucarbotran and LS-oo8 for MPI applications.

Conclusions:

• 3D MPI is a powerful tool for quantitative assessment of SPIO tracer biodistribution and clearance.
• This imaging modality holds significant promise for various clinical applications, including cell tracking and cancer detection.
• The study confirms the in vivo applicability of Ferucarbotran and LS-oo8 for MPI.